Jump to content

Squalene monooxygenase

From Wikipedia, the free encyclopedia

SQLE
Identifiers
AliasesSQLE, entrez:6713, squalene epoxidase
External IDsOMIM: 602019; MGI: 109296; GeneCards: SQLE
Enzyme activity
EC #BRENDAExPASyKEGGMetaCyc
1.14.14.17↗↗↗↗
Orthologs
DatabasesNCBI: entry; OMA: entry
SpeciesHumanMouse
Entrez
Ensembl
UniProt
RefSeq (mRNA)

NM_003129

NM_009270

RefSeq (protein)

NP_003120

NP_033296

Location (UCSC)Chr 8: 125 – 125.02 MbChr 15: 59.19 – 59.2 Mb
PubMed search[3][4]
Wikidata
View/Edit HumanView/Edit Mouse

Squalene monooxygenase (also called squalene epoxidase) is a eukaryotic enzyme that uses NADPH and diatomic oxygen to oxidize squalene to 2,3-oxidosqualene (squalene epoxide). Squalene epoxidase catalyzes the first oxygenation step in sterol biosynthesis and is thought to be one of the rate-limiting enzymes in this pathway.[5] In humans, squalene epoxidase is encoded by the SQLE gene.[6] Several eukaryote genomes lack a squalene monooxygenase encoding gene, but instead encode an alternative squalene epoxidase that performs the same task.[7]

Mechanism

[edit]

The canonical squalene monooxygenase is a flavoprotein monooxygenase. Flavoprotein monooxygenase form flavin hydroperoxides at the enzyme active site, which then transfer the terminal oxygen atom of the hydroperoxide to the substrate. Squalene monooxygenase differs from other flavin monooxygenases in that the oxygen is inserted into the substrate as an epoxide rather than as a hydroxyl group. This enzyme contains a loosely bound FAD flavin and obtains electrons from NADPH-cytochrome P450 reductase, rather than binding NADPH directly. The alternative squalene epoxidase belongs to the fatty acid hydroxylase superfamily and obtains electrons from cytochrome b5.[7]

Known crystal structures

[edit]

Researchers identified crystal structures of squalene epoxidase in the human genome. One crystal structure was found on the domain that binds the inhibitor Cmpd-4 with a FAD cofactor at 2.30Å. The other crystal structure is found on the domain that binds another inhibitor, NB-598, with FAD at 2.50Å.[8] In its unliganded, apo form (3.0 Å), squalene epoxidase displays greater displacement of the substrate-binding site compared to the liganded domains that bind with the FAD cofactor. This encloses polar residues, preventing binding to the tertiary amine of an inhibitor, and significantly reduces squalene epoxidase's catalytic activity in converting squalene to 2,3-oxidosqualene[8] Although this enzyme is present in baker's yeast(Saccharomyces cerevisiae) and other mammals, no genes encoding specific crystal structures have been discovered.

Active sites

[edit]

There is only one active site located in the catalytic domain of squalene epoxidase. In the active site, the FAD-binding domain consists of a three-layer ββα sandwich structure also known as the GR2 Rossmann fold[9]Within the FAD-binding domain, FAD-binding motifs, including G-Box, GD- and DG-motifs, are present, which is typical of flavin epoxidases. The GD motif is critical for recognizing the NADPH cofactor that supplies the necessary electrons for the oxidation reaction. The substrate-binding site consists of a two-layer βα sandwich domain with a seven-stranded β-sheet structure, followed by two helices at the C-terminus.[9]

Squalene epoxidase's role in sharks

[edit]

In addition to humans and baker's yeast, squalene epoxidase is present in all species of sharks. Shark livers typically consist of 40-60% squalene, with some deep-sea species' liver, like the smallfin gulper shark(Centrophorus moluccensis), containing 93% squalene.[10] Due to a lack of a swim bladder and a negatively buoyant body structure, oil content in shark livers is the main control for a shark's positive buoyancy in the water column. Squalene epoxidase is used to maintain squalene levels in order to achieve neutral buoyancy while swimming in the marine environment.[11]

Inhibitors

[edit]

Inhibitors of squalene epoxidase have found application mainly as antifungal drugs:[12]

Since squalene epoxidase is on the biosynthetic pathway leading to production of cholesterol, inhibitors of this enzyme may also find application in treatment of hypercholesterolemia.[14]

Localization

[edit]

In baker's yeast, squalene epoxidase is localized to both the endoplasmic reticulum and lipid droplets. Only the ER localized protein is active.

Additional products

[edit]

Squalene epoxidase also catalyzes the formation of diepoxysqualene (DOS). DOS is converted to 24(S),25-epoxylanosterol by lanosterol synthase.

See also

[edit]

References

[edit]
  1. 1 2 3 GRCh38: Ensembl release 89: ENSG00000104549 – Ensembl, May 2017
  2. 1 2 3 GRCm38: Ensembl release 89: ENSMUSG00000022351 – Ensembl, May 2017
  3. ↑ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. ↑ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. ↑ "Entrez Gene: SQLE squalene epoxidase".
  6. ↑ Nagai M, Sakakibara J, Wakui K, Fukushima Y, Igarashi S, Tsuji S, et al. (August 1997). "Localization of the squalene epoxidase gene (SQLE) to human chromosome region 8q24.1". Genomics. 44 (1): 141–143. doi:10.1006/geno.1997.4825. PMID 9286711.
  7. 1 2 Pollier J, Vancaester E, Kuzhiumparambil U, Vickers CE, Vandepoele K, Goossens A, et al. (2019). "A widespread alternative squalene epoxidase participates in eukaryote steroid biosynthesis". Nature Microbiology. 4 (2): 226–233. doi:10.1038/s41564-018-0305-5. hdl:1854/LU-8587985. PMID 30478288. S2CID 53726187.
  8. 1 2 Padyana AK, Gross S, Jin L, Cianchetta G, Narayanaswamy R, Wang F, et al. (January 2019). "Structure and inhibition mechanism of the catalytic domain of human squalene epoxidase". Nature Communications. 10 (1) 97. doi:10.1038/s41467-018-07928-x. PMC 6327030. PMID 30626872.
  9. 1 2 Brown AJ, Chua NK, Yan N (February 2019). "The shape of human squalene epoxidase expands the arsenal against cancer". Nature Communications. 10 (1) 888. doi:10.1038/s41467-019-08866-y. PMC 6384927. PMID 30792392.
  10. ↑ PHLEGER CH (2015-08-01). "Buoyancy in Marine Fishes: Direct and Indirect Role of Lipids". American Zoologist. 38 (2): 321–330. doi:10.1093/icb/38.2.321. ISSN 0003-1569.
  11. ↑ Patel A, Bettiga M, Rova U, Christakopoulos P, Matsakas L (October 2022). "Microbial genetic engineering approach to replace shark livering for squalene". Trends in Biotechnology. 40 (10): 1261–1273. doi:10.1016/j.tibtech.2022.03.008. PMID 35450778.
  12. ↑ Favre B, Ryder NS (February 1996). "Characterization of squalene epoxidase activity from the dermatophyte Trichophyton rubrum and its inhibition by terbinafine and other antimycotic agents". Antimicrobial Agents and Chemotherapy. 40 (2): 443–447. doi:10.1128/AAC.40.2.443. PMC 163131. PMID 8834895.
  13. ↑ Ryder NS (February 1992). "Terbinafine: mode of action and properties of the squalene epoxidase inhibition". The British Journal of Dermatology. 126 (Suppl 39): 2–7. doi:10.1111/j.1365-2133.1992.tb00001.x. PMID 1543672. S2CID 19780957.
  14. ↑ Chugh A, Ray A, Gupta JB (January 2003). "Squalene epoxidase as hypocholesterolemic drug target revisited". Progress in Lipid Research. 42 (1): 37–50. doi:10.1016/S0163-7827(02)00029-2. PMID 12467639.

Further reading

[edit]
[edit]

This article incorporates text from the United States National Library of Medicine, which is in the public domain.